The association between frailty index and all-cause mortality in US individuals with kidney stones: mediation by systemic immune-inflammation (SII) index.
{"title":"The association between frailty index and all-cause mortality in US individuals with kidney stones: mediation by systemic immune-inflammation (SII) index.","authors":"Shuangning Liu, Yu Dai, YanHu Meng, Jie Zhang, Xiaoke Sun, Yatao Jia","doi":"10.1007/s00240-025-01837-7","DOIUrl":null,"url":null,"abstract":"<p><p>The relationship between the frailty index (FI) and all-cause mortality in patients with kidney stones remains unclear, and whether this relationship is mediated by the systemic Immune-Inflammation index (SII). This cohort study analyzed data from the National Health and Nutrition Examination Survey (NHANES) in the United States, spanning 2007 to 2018. Utilizing Kaplan-Meier survival curves, Cox regression analysis, restricted cubic splines (RCS), and mediation analysis, the research investigated the relationships between FI, SII, and all-cause mortality in individuals with kidney stones. During a median follow-up of 6.3 years (16695 person-years) ,356 total deaths were recorded. A cohort of 2,620 U.S. participants was enrolled from NHANES 2007-2018. Frail individuals demonstrated significantly higher all-cause mortality compared to non-frail counterparts (HR = 1.78, 95% CI: 1.56-2.02, P < 0 0.001). Among patients with kidney stones, the FI showed a positive correlation with the SII (β = 38.18, 95% CI: 10.38-65.99, P < 0.01). The SII indirectly influenced the FI and all-cause mortality in these patients, accounting for 5.6% of the mediating effect. Among U.S. adults with kidney stones, the FI is linked to a higher risk of all-cause mortality, with SII potentially serving as a biological mechanism.</p>","PeriodicalId":23411,"journal":{"name":"Urolithiasis","volume":"53 1","pages":"166"},"PeriodicalIF":2.2000,"publicationDate":"2025-08-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12399735/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Urolithiasis","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s00240-025-01837-7","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"UROLOGY & NEPHROLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
The relationship between the frailty index (FI) and all-cause mortality in patients with kidney stones remains unclear, and whether this relationship is mediated by the systemic Immune-Inflammation index (SII). This cohort study analyzed data from the National Health and Nutrition Examination Survey (NHANES) in the United States, spanning 2007 to 2018. Utilizing Kaplan-Meier survival curves, Cox regression analysis, restricted cubic splines (RCS), and mediation analysis, the research investigated the relationships between FI, SII, and all-cause mortality in individuals with kidney stones. During a median follow-up of 6.3 years (16695 person-years) ,356 total deaths were recorded. A cohort of 2,620 U.S. participants was enrolled from NHANES 2007-2018. Frail individuals demonstrated significantly higher all-cause mortality compared to non-frail counterparts (HR = 1.78, 95% CI: 1.56-2.02, P < 0 0.001). Among patients with kidney stones, the FI showed a positive correlation with the SII (β = 38.18, 95% CI: 10.38-65.99, P < 0.01). The SII indirectly influenced the FI and all-cause mortality in these patients, accounting for 5.6% of the mediating effect. Among U.S. adults with kidney stones, the FI is linked to a higher risk of all-cause mortality, with SII potentially serving as a biological mechanism.
期刊介绍:
Official Journal of the International Urolithiasis Society
The journal aims to publish original articles in the fields of clinical and experimental investigation only within the sphere of urolithiasis and its related areas of research. The journal covers all aspects of urolithiasis research including the diagnosis, epidemiology, pathogenesis, genetics, clinical biochemistry, open and non-invasive surgical intervention, nephrological investigation, chemistry and prophylaxis of the disorder. The Editor welcomes contributions on topics of interest to urologists, nephrologists, radiologists, clinical biochemists, epidemiologists, nutritionists, basic scientists and nurses working in that field.
Contributions may be submitted as full-length articles or as rapid communications in the form of Letters to the Editor. Articles should be original and should contain important new findings from carefully conducted studies designed to produce statistically significant data. Please note that we no longer publish articles classified as Case Reports. Editorials and review articles may be published by invitation from the Editorial Board. All submissions are peer-reviewed. Through an electronic system for the submission and review of manuscripts, the Editor and Associate Editors aim to make publication accessible as quickly as possible to a large number of readers throughout the world.